IMRIS to Acquire MR-Compatible Surgical Robot Technology
-- MacDonald, Dettwiler to Partner with IMRIS on Next Generation Surgical Robot --
The robotic surgery system is designed to perform microsurgery and biopsy-stereotaxy applications on the brain with unprecedented precision. To management's knowledge, it is the only surgical robot in the world that a surgeon can use together with a magnetic resonance (MR) scanner in the operating room.
"This acquisition will deepen IMRIS's offering of image guided therapy solutions, by bringing surgical robotics together with MR imaging," said
IMRIS will issue 1.6 million common shares as consideration for the acquisition of NASL, including the technology, patents and associated intellectual property. IMRIS and MDA will work together to commercialize the technology. MDA, a world leader in robotics and developer of the Canadarm, played a key role in creating the current NASL robotic surgery system.
"We have developed three generations of robotic systems for the International Space Station - expertise that was instrumental in the development of the first NeuroArm," said
The system features two robotic arms that can manipulate MR-compatible tools at microscopic scale from a remote workstation. The surgeon sees detailed three-dimensional images of the brain and surgical tools, and uses hand controllers equipped with enhanced touch sensation that allows the surgeon to 'feel' very small anatomy through the robotic arms and surgical tools.
The first generation robot was developed at the University of
"With the same disciplined approach we have consistently applied in building our business, we are acquiring a proven technology with tremendous potential applications,"
Analyst Conference Call Today
IMRIS will host a conference call to discuss the announced acquisition of NASL today at
IMRIS (TSX: IM) is a global leader in providing image guided therapy solutions. These solutions feature fully integrated surgical and interventional suites that incorporate magnetic resonance, fluoroscopy and computed tomography to deliver on demand imaging during procedures. The Company's systems serve the neurosurgical, cardiovascular and neurovascular markets and have been selected by leading medical institutions around the world.
About MacDonald, Dettwiler and Associates Ltd. (MDA)
MDA provides advanced information solutions that capture and process vast amounts of data, produce essential information, and improve the decision making and operational performance of business and government organizations worldwide. Focused on markets and customers with strong repeat business potential, MDA delivers a broad spectrum of information solutions, ranging from complex operational systems, to tailored information services, to electronic information products. MDA employs more than 3,200 people in locations across the
This press release contains and refers to forward-looking information based on current expectations. In some cases, forward-looking statements can be identified by terminology such as "will", "anticipate", "may", "expect", "believe", "prospective", "continue" or the negative of these terms or other similar expressions concerning matters that are not historical facts. These statements should not be understood as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors, including the ability of the parties to satisfy all of the closing conditions to complete the transaction, our ability to successfully develop the next generation of the NeuroArm technology, our ability to commercialize the NeuroArm system and our reliance on our strategic partners including MDA and the University of